Evidence map›Paper›PMID 37823315›Full record

ArticleThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2023

Evaluation of Development of Nonalcoholic Fatty Pancreas Disease After Post-Endoscopic Retrograde Cholangiop ancreatography Pancreatitis in Liver Transplant Patients: Computerized Tomography Versus Ultrasound.

Ayşe Nuransoy Cengiz, Yılmaz Bilgiç, Sinan Karatoprak, Ayşe Gökçe, Bahri Evren, Sami Akbulut, Sezai Yılmaz

Open access · diamondAbstract read
In one paragraph

Article in The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Validity and Diagnostic Ability of Pancreatic Exocrine Insufficiency Questionnaire in Turkish Patients.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ayşe Nuransoy CengizDivision of Internal Medicine, Kahramanmaraş Elbistan State Hospital, Kahramanmaraş, Turkey.
Yılmaz BilgiçDivision of Internal Medicine, Department of Gastroenterology, İnönü University Faculty of Medicine, Turgut Özal Medical Center, Malatya, Turkey.
Sinan KaratoprakDepartment of Radiology, İnönü University Faculty of Medicine, Turgut Özal Medical Center, Malatya, Turkey.
Ayşe GökçeDepartment of Public Health, İnönü University Faculty of Medicine, Turgut Özal Medical Center, Malatya, Turkey.
Bahri EvrenDepartment of Endocrinology, İnönü University Faculty of Medicine, Turgut Özal Medical Center, Malatya, Turkey.
Sami AkbulutDepartment of Surgery and Liver Transplant Institute, Turgut Özal Medical Center, Malatya, Turkey.
Sezai YılmazDepartment of Surgery and Liver Transplant Institute, Turgut Özal Medical Center, Malatya, Turkey.
Inonu University · TRTurgut Özal Tıp Merkezi · TRKahramanmaraş Sütçü İmam University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsPost-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is the most common serious adverse event in liver transplant patients The average incidence has been reported as 1.3%-15.1% in prospective series. In our study, we have prospectively evaluated the prevalence of nonalcoholic fatty pancreatic disease (NAFPD) after PEP via computerized tomography (CT) and determined the ratio of fatty pancreas by ultrasound imaging in liver transplant patients. MATERIALS AND

methodsWe have retrospectively analyzed 2922 patient files, and 146 patients were indicated for ERCP. PEP was observed in 32 patients. After presenting the significant association between the NAFPD and PEP, we prospectively reached 32 patients included in the study. Ten out of those patients have been performed ultrasound with regard to NAFPD.

resultsPEP was defined in 32 patients in whom CT was performed to investigate NAFPD. When the patients were contacted, it was observed that 12% were deceased, 71% were alive, but 15% of them were untraceable. Ultrasound has been performed on 10 of 32 patients to determine NAFPD. There was a significant reduction in post-PEP pancreas/spleen rate compared to pre-PEP pancreas/ spleen rate (P = .001). Both the pre-PEP and post-PEP pancreas-spleen difference dropped significantly (P = .002).

conclusionUltrasound imaging could be utilized as a scanning test and an alternative to evaluate and diagnose NAFPD, particularly in risky patients.

Indexed as

Cholangiopancreatography, Endoscopic RetrogradeLiver TransplantationPancreatitisTomography, X-Ray ComputedUltrasonographyHumansNon-alcoholic Fatty Liver DiseasePancreasRetrospective StudiesRisk Factors

Identifiers

PMID37823315
PMCPMC10724822
OpenAlexW4387562897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.